SYNNEX Corp. (SNX) Tops Q3 EPS by 4c; Issues Q4 Outlook

SYNNEX Corp. (NYSE: SNX) reported Q3 EPS of $1.47, $0.04 better than the analyst estimate of $1.43. Revenue for the quarter came in at $3.33 billion versus the consensus estimate of $3.35 billion.

SYNNEX Corp. sees Q4 2015 EPS of $1.74-$1.79, versus the consensus of $1.78. SYNNEX Corp. sees Q4 2015 revenue of $3.48-3.58 billion, versus the consensus of $3.72 billion.

For earnings history and earnings-related data on SYNNEX Corp. (SNX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c